St. Luke’s University Health Network (SLUHN) heart specialists are the first in the Lehigh Valley region to employ advanced ...

The U.S. Food and Drug Administration has approved Edwards Lifesciences' SAPIEN 3 platform, a transcatheter aortic valve ...

Aortic stenosis is a narrowing of the aortic valve opening, which restricts blood flow from the heart to the rest of the body ...

Ord Minnett is approaching investors with another capital raising for Echo IQ, a $200 million market-capped stock focused on ...

Not surprisingly, older patients fared worse, but some older and younger patients saw stroke benefits requiring more study.

New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...

A pioneering heart centre at Basildon Hospital is celebrating a major milestone after carrying out its 1,000th "life-changing procedure". The Essex Cardiothoracic Centre (CTC), based at Basildon ...

FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis ...

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...

A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be ...

Abdominal aortic aneurysm (AAA) repair has undergone a remarkable transformation over the last 2 decades, primarily driven by ...

Normal E/A ratio of about 1:2 in an elderly patient with aortic stenosis and left ventricular hypertrophy is indicative of pseudo-normalization (see Figure 7). PW=pulsed wave; MV DT=mitral valve ...